Back for its 11th Annual edition, this global bio-pharma industry forum addresses through its conference programme the main challenges for 2018 in investment, partnering and alliance management. Key players contribute their insights in panels which cover the macro picture as well as innovation in the different therapeutic sectors. The Forum also features keynote speeches by KOL, about 60 selected corporate presentations from established (public and private) and emerging biotechs seeking to promote investment and partnering opportunities.
Dr Dirk Beher will be panellist on the "Neuroscience Advanced Therapies and Diagnostics Panel " on February 26th, at 12:15 PM. Dr Beher will also make a company presentation on February 26th, at 2:00 PM.